Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: J Subst Abuse Treat. 2017 Jul 14;81:1–10. doi: 10.1016/j.jsat.2017.07.007

Table 3.

Association of type of sedating medication and risk of lifetime and past-year non-fatal overdose

Medication type Lifetime Overdose
OR (95%CI)
p-value Past-year Overdose
OR (95%CI)
p-value
Any opioid medication a 2.31 (1.37, 3.90) 0.002 2.23 (0.93, 5.35) 0.07
Any non-opioid sedating medication a 1.18 (0.66, 2.13) 0.57 1.99 (0.66, 5.94) 0.22
Any opioid agonist treatment medication b 4.79 (2.53, 9.08) <0.001 2.73 (1.20, 6.19) 0.01
Any opioid medication for pain b 1.11 (0.59, 2.10) 0.74 0.81 (0.27, 2.45) 0.71
Any non-opioid sedating medication b 1.18 (0.66, 2.13) 0.57 1.99 (0.66, 5.94) 0.22
a

Results of one unadjusted logistic regression model that included ”any opioid medication” and “any non-opioid sedating medication”

b

Results of one unadjusted logistic regression model that included ”any opioid agonist treatment medication” (buprenorphine or methadone), “any opioid medication for pain (all other opioid medications) and any non-opioid sedating medication.